US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

33.73

-0.0800-0.24%

Volume:987.57K

Turnover:33.34M

Market Cap:2.96B

PE:-18.51

High:34.16

Open:33.70

Low:33.42

Close:33.81

52wk High:37.08

52wk Low:13.45

Shares:87.67M

Float Shares:81.82M

Volume Ratio:1.21

T/O Rate:1.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8227

EPS(LYR):-3.3605

ROE:-14.15%

ROA:-10.77%

PB:2.71

PE(LYR):-10.04

Loading ...

Overview Company News Filings

IDEAYA Biosciences (IDYA): Valuation Check After Key Darovasertib Trial Milestone and Pipeline Progress

Simply Wall St.

Sector Update: Health Care Stocks Mixed Premarket Thursday

MT Newswires Live

IDEAYA Biosciences Completes Enrollment in Pivotal Phase 2/3 Trial of Darovasertib and Crizotinib for Metastatic Uveal Melanoma

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (Optimum-02) of Darovasertib in Combination With Crizotinib in First-Line Hla*a2-Negative Metastatic Uveal Melanoma

THOMSON REUTERS

IDEAYA Biosciences Inc - Topline Data Expected in 1Q 2026

THOMSON REUTERS

IDEAYA Biosciences Submits US FDA Investigational New Drug Application for Potential Cancer Therapy

MT Newswires Live

BRIEF-Ideaya Biosciences Announces Ind Submission For Ide574

IDEAYA Biosciences- Phase 1 Dose Escalation Trial of Monotherapy Ide574 Expected to Begin in 1Q 2026

THOMSON REUTERS

IDEAYA Biosciences Announces Ind Submission for Ide574, a Potential First-in-Class Kat6/7 Dual Inhibitor for Breast and Lung Cancers

THOMSON REUTERS

IDEAYA Biosciences Inc - Preclinical Data for Ide574 to Be Presented in 1H 2026

THOMSON REUTERS

Is GSK’s Exit and IDE034’s FDA Green Light Reframing the Investment Case For IDEAYA Biosciences (IDYA)?

Simply Wall St.

Taking Stock of IDEAYA Biosciences (IDYA) Valuation After FDA Clears IDE034 for Phase 1 Trial

Simply Wall St.

IDEAYA Biosciences Inc - to Evaluate Strategic Options for Programs in 2026 - SEC Filing

THOMSON REUTERS

IDEAYA Biosciences:on December 4, Glaxosmithkline Intellectual Property Terminated Collaboration Agreement With IDEAYA Biosciences - SEC Filing

THOMSON REUTERS

IDEAYA and Biocytogen Receive FDA Clearance for IND Application of IDE034

BUZZ-U.S. STOCKS ON THE MOVE-Ideaya Biosciences, Omnicom Group, Targa Resources

Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires Live

BUZZ-Ideaya rises as FDA clears trial for experimental cancer drug

BRIEF-Ideaya Biosciences Announces Clearance For IDE034

IDEAYA Biosciences Receives FDA IND Clearance for Phase 1 Trial of IDE034 in Solid Tumors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IDYA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":33.73,"timestamp":1766005200000,"preClose":33.81,"halted":0,"volume":987571,"delay":0,"floatShares":81816082,"shares":87666408,"eps":-1.822728,"marketStatus":"Pre-Mkt","change":-0.08,"latestTime":"12-18 04:28:29 EST","open":33.7,"high":34.16,"low":33.4201,"amount":33338534.401094,"amplitude":0.021884,"askPrice":42.44,"askSize":100,"bidPrice":32.71,"bidSize":226,"shortable":3,"etf":0,"ttmEps":-1.822728,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766068200000},"marketStatusCode":1,"adr":0,"listingDate":1558584000000,"exchange":"NASDAQ","adjPreClose":33.73,"postHourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"19:22 EST","volume":15003,"amount":506039.45,"timestamp":1766017322426},"volumeRatio":1.2072741257763284,"impliedVol":1.3171,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","floatShares":81816082,"roa":"-10.77%","roe":"-14.15%","lyrEps":-3.360473,"volumeRatio":1.2072741257763284,"shares":87666408,"dividePrice":0,"high":34.16,"amplitude":0.021884,"preClose":33.81,"low":33.4201,"week52Low":13.45,"pbRate":"2.71","psRate":"13.76","week52High":37.08,"institutionHeld":0,"latestPrice":33.73,"committee":0.386503,"eps":-1.822728,"divideRate":0,"volume":987571,"delay":0,"ttmEps":-1.822728,"open":33.7,"prevYearClose":25.7,"prevWeekClose":34.02,"prevMonthClose":35.62,"prevQuarterClose":27.21,"fiveDayClose":33.64,"twentyDayClose":33.71,"sixtyDayClose":25.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"IDYA","fiscalQuarterEnding":"2025/09","expectedEps":0,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":1.33},{"market":"US","date":"2025-08-05","symbol":"IDYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.85,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-05-06","symbol":"IDYA","fiscalQuarterEnding":"2025/03","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2025-02-13","symbol":"IDYA","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":-1.49},{"market":"US","date":"2024-11-04","symbol":"IDYA","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1764046800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IDYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IDYA","date":"2025-12-16","current":-18.50523,"percent":0.433333,"low":-34.624829,"twenty":-22.797965,"median":-16.380114,"eighty":-8.45396,"high":-4.624403,"avg":-16.581313,"sd":7.597553,"marketCap":2925428034},"quantilePoints":[{"date":"2020-12-18","current":-9.453166,"twenty":-7.919802,"median":-4.333623,"eighty":-3.310899,"marketCap":379459527},{"date":"2020-12-24","current":-9.337354,"twenty":-8.007327,"median":-4.345911,"eighty":-3.319882,"marketCap":374810712},{"date":"2020-12-31","current":-10.133562,"twenty":-8.091015,"median":-4.369631,"eighty":-3.320843,"marketCap":406771316},{"date":"2021-01-08","current":-10.126324,"twenty":-8.123554,"median":-4.38073,"eighty":-3.326128,"marketCap":406480765},{"date":"2021-01-15","current":-12.196466,"twenty":-8.150562,"median":-4.396081,"eighty":-3.333257,"marketCap":489578333},{"date":"2021-01-22","current":-13.318396,"twenty":-8.217153,"median":-4.425522,"eighty":-3.338699,"marketCap":534613729},{"date":"2021-01-29","current":-12.724859,"twenty":-8.273693,"median":-4.46871,"eighty":-3.3391,"marketCap":510788552},{"date":"2021-02-05","current":-13.933648,"twenty":-8.323951,"median":-4.508424,"eighty":-3.363122,"marketCap":559310559},{"date":"2021-02-12","current":-13.687547,"twenty":-8.361644,"median":-4.550006,"eighty":-3.367926,"marketCap":549431827},{"date":"2021-02-19","current":-12.999913,"twenty":-8.520656,"median":-4.585646,"eighty":-3.370227,"marketCap":521829488},{"date":"2021-02-26","current":-13.803359,"twenty":-8.627473,"median":-4.598275,"eighty":-3.372345,"marketCap":554080642},{"date":"2021-03-05","current":-14.33899,"twenty":-8.66338,"median":-4.631301,"eighty":-3.402009,"marketCap":575581412},{"date":"2021-03-12","current":-16.611804,"twenty":-8.7798,"median":-4.691605,"eighty":-3.410799,"marketCap":666814407},{"date":"2021-03-19","current":-16.343988,"twenty":-8.84035,"median":-4.717677,"eighty":-3.415564,"marketCap":656064022},{"date":"2021-03-26","current":-21.126111,"twenty":-8.941508,"median":-4.791351,"eighty":-3.418925,"marketCap":728745203},{"date":"2021-04-01","current":-22.285243,"twenty":-9.163635,"median":-4.928537,"eighty":-3.41949,"marketCap":768729453},{"date":"2021-04-09","current":-18.564804,"twenty":-9.293924,"median":-5.059353,"eighty":-3.428909,"marketCap":640392909},{"date":"2021-04-16","current":-17.396324,"twenty":-9.505281,"median":-5.10129,"eighty":-3.441013,"marketCap":600086205},{"date":"2021-04-23","current":-19.003246,"twenty":-9.670314,"median":-5.186016,"eighty":-3.447944,"marketCap":655516972},{"date":"2021-04-30","current":-19.594416,"twenty":-9.739801,"median":-5.226626,"eighty":-3.452635,"marketCap":675909371},{"date":"2021-05-07","current":-18.288121,"twenty":-9.832451,"median":-5.324735,"eighty":-3.459277,"marketCap":630848747},{"date":"2021-05-14","current":-20.393803,"twenty":-10.104609,"median":-5.514956,"eighty":-3.464141,"marketCap":641854163},{"date":"2021-05-21","current":-21.240496,"twenty":-10.279775,"median":-5.63553,"eighty":-3.465219,"marketCap":668502132},{"date":"2021-05-28","current":-21.062795,"twenty":-10.625764,"median":-5.656499,"eighty":-3.474365,"marketCap":662909349},{"date":"2021-06-04","current":-20.989624,"twenty":-11.26273,"median":-5.676643,"eighty":-3.484294,"marketCap":660606438},{"date":"2021-06-11","current":-21.836317,"twenty":-12.053148,"median":-5.777074,"eighty":-3.496371,"marketCap":687254407},{"date":"2021-06-18","current":-23.717857,"twenty":-12.533769,"median":-5.971041,"eighty":-3.508471,"marketCap":746472115},{"date":"2021-06-25","current":-22.484403,"twenty":-12.898577,"median":-6.065403,"eighty":-3.513532,"marketCap":707651617},{"date":"2021-07-02","current":-23.059318,"twenty":-13.144678,"median":-6.217431,"eighty":-3.51557,"marketCap":725745917},{"date":"2021-07-09","current":-21.049231,"twenty":-13.370511,"median":-6.264612,"eighty":-3.517045,"marketCap":662482433},{"date":"2021-07-16","current":-22.691914,"twenty":-13.607926,"median":-7.020167,"eighty":-3.52146,"marketCap":714182615},{"date":"2021-07-23","current":-26.682771,"twenty":-13.783092,"median":-7.08007,"eighty":-3.524544,"marketCap":839786849},{"date":"2021-07-30","current":-29.809753,"twenty":-14.04946,"median":-7.153433,"eighty":-3.531687,"marketCap":938202363},{"date":"2021-08-06","current":-28.191509,"twenty":-14.587986,"median":-7.224561,"eighty":-3.533947,"marketCap":887271377},{"date":"2021-08-13","current":-29.97068,"twenty":-15.154018,"median":-7.242857,"eighty":-3.537369,"marketCap":899989535},{"date":"2021-08-20","current":-30.290333,"twenty":-16.287529,"median":-7.254477,"eighty":-3.541434,"marketCap":909588400},{"date":"2021-08-27","current":-29.305801,"twenty":-16.592186,"median":-7.303089,"eighty":-3.542962,"marketCap":880023897},{"date":"2021-09-03","current":-31.722379,"twenty":-16.958969,"median":-7.318795,"eighty":-3.549073,"marketCap":952591312},{"date":"2021-09-10","current":-33.985523,"twenty":-17.480455,"median":-7.331359,"eighty":-3.549073,"marketCap":1020551273},{"date":"2021-09-17","current":-34.343535,"twenty":-18.002071,"median":-7.384758,"eighty":-3.550496,"marketCap":1031302001},{"date":"2021-09-24","current":-32.451188,"twenty":-18.564804,"median":-7.425593,"eighty":-3.554316,"marketCap":974476724},{"date":"2021-10-01","current":-32.655766,"twenty":-19.003246,"median":-7.482701,"eighty":-3.556676,"marketCap":980619997},{"date":"2021-10-08","current":-32.70691,"twenty":-19.603951,"median":-7.576366,"eighty":-3.556676,"marketCap":982155815},{"date":"2021-10-15","current":-29.57431,"twenty":-19.948284,"median":-7.607522,"eighty":-3.556676,"marketCap":888086943},{"date":"2021-10-22","current":-29.305801,"twenty":-20.299726,"median":-7.64547,"eighty":-3.561126,"marketCap":880023897},{"date":"2021-10-29","current":-27.413454,"twenty":-20.498333,"median":-7.666222,"eighty":-3.5648,"marketCap":823198619},{"date":"2021-11-05","current":-30.149685,"twenty":-20.989624,"median":-7.758551,"eighty":-3.569714,"marketCap":905364899},{"date":"2021-11-12","current":-29.446448,"twenty":-21.062795,"median":-7.793103,"eighty":-3.570043,"marketCap":884247397},{"date":"2021-11-19","current":-24.362497,"twenty":-21.240496,"median":-7.827655,"eighty":-3.571919,"marketCap":893738217},{"date":"2021-11-26","current":-24.981527,"twenty":-21.39159,"median":-7.890477,"eighty":-3.574612,"marketCap":916447328},{"date":"2021-12-03","current":-23.145422,"twenty":-21.857223,"median":-7.96045,"eighty":-3.584136,"marketCap":849089797},{"date":"2021-12-10","current":-22.914597,"twenty":-22.068374,"median":-8.022404,"eighty":-3.586999,"marketCap":840621993},{"date":"2021-12-17","current":-22.841153,"twenty":-22.307678,"median":-8.080851,"eighty":-3.590242,"marketCap":837927691},{"date":"2021-12-23","current":-24.519878,"twenty":-22.478131,"median":-8.112599,"eighty":-3.600896,"marketCap":899511720},{"date":"2021-12-31","current":-24.803163,"twenty":-22.661484,"median":-8.124771,"eighty":-3.607486,"marketCap":909904025},{"date":"2022-01-07","current":-18.854181,"twenty":-22.696715,"median":-8.133171,"eighty":-3.607884,"marketCap":691665623},{"date":"2022-01-14","current":-18.6968,"twenty":-22.661484,"median":-8.166895,"eighty":-3.6108,"marketCap":685892120},{"date":"2022-01-21","current":-16.01084,"twenty":-22.62885,"median":-8.217153,"eighty":-3.61443,"marketCap":587357674},{"date":"2022-01-28","current":-16.304617,"twenty":-22.589226,"median":-8.232117,"eighty":-3.61955,"marketCap":598134879},{"date":"2022-02-04","current":-16.336093,"twenty":-22.528306,"median":-8.279975,"eighty":-3.626979,"marketCap":599289580},{"date":"2022-02-11","current":-15.95838,"twenty":-22.480222,"median":-8.317669,"eighty":-3.641021,"marketCap":585433173},{"date":"2022-02-18","current":-14.290147,"twenty":-22.452959,"median":-8.349952,"eighty":-3.663377,"marketCap":524234045},{"date":"2022-02-25","current":-14.300639,"twenty":-22.416661,"median":-8.361644,"eighty":-3.680345,"marketCap":524618945},{"date":"2022-03-04","current":-12.663882,"twenty":-22.374982,"median":-8.467308,"eighty":-3.689682,"marketCap":464574517},{"date":"2022-03-11","current":-13.4298,"twenty":-22.27281,"median":-8.578381,"eighty":-3.700816,"marketCap":492672230},{"date":"2022-03-18","current":-9.803903,"twenty":-22.210534,"median":-8.63295,"eighty":-3.710538,"marketCap":487861813},{"date":"2022-03-25","current":-8.880178,"twenty":-22.137363,"median":-8.648165,"eighty":-3.728362,"marketCap":441895419},{"date":"2022-04-01","current":-8.849128,"twenty":-22.038758,"median":-8.676953,"eighty":-3.732947,"marketCap":440350330},{"date":"2022-04-08","current":-8.771505,"twenty":-22.005987,"median":-8.686118,"eighty":-3.735526,"marketCap":436487608},{"date":"2022-04-14","current":-8.39891,"twenty":-21.980806,"median":-8.678356,"eighty":-3.739591,"marketCap":417946542},{"date":"2022-04-22","current":-8.297999,"twenty":-21.967416,"median":-8.654251,"eighty":-3.742674,"marketCap":412925003},{"date":"2022-04-29","current":-7.445176,"twenty":-21.940847,"median":-8.644345,"eighty":-3.747479,"marketCap":370486844},{"date":"2022-05-06","current":-7.080292,"twenty":-21.836317,"median":-8.631683,"eighty":-3.752283,"marketCap":352329512},{"date":"2022-05-13","current":-7.388684,"twenty":-21.606351,"median":-8.578381,"eighty":-3.771501,"marketCap":404559983},{"date":"2022-05-20","current":-7.762705,"twenty":-21.554086,"median":-8.467308,"eighty":-3.779737,"marketCap":425039142},{"date":"2022-05-27","current":-7.621565,"twenty":-21.406546,"median":-8.392554,"eighty":-3.780239,"marketCap":417311157},{"date":"2022-06-03","current":-8.397835,"twenty":-21.39159,"median":-8.36786,"eighty":-3.788369,"marketCap":459815071},{"date":"2022-06-10","current":-8.037928,"twenty":-21.387041,"median":-8.380207,"eighty":-3.794466,"marketCap":440108711},{"date":"2022-06-17","current":-8.729514,"twenty":-21.336664,"median":-8.392554,"eighty":-3.799547,"marketCap":477975835},{"date":"2022-06-24","current":-9.795122,"twenty":-21.273946,"median":-8.39891,"eighty":-3.80666,"marketCap":536322117},{"date":"2022-07-01","current":-10.10563,"twenty":-21.225131,"median":-8.471248,"eighty":-3.810725,"marketCap":553323683},{"date":"2022-07-08","current":-10.888958,"twenty":-21.198073,"median":-8.557964,"eighty":-3.815416,"marketCap":596213996},{"date":"2022-07-15","current":-10.938357,"twenty":-21.154154,"median":-8.623821,"eighty":-3.823859,"marketCap":598918791},{"date":"2022-07-22","current":-10.50788,"twenty":-21.113328,"median":-8.640812,"eighty":-3.827243,"marketCap":575348438},{"date":"2022-07-29","current":-10.529051,"twenty":-21.08161,"median":-8.648165,"eighty":-3.852269,"marketCap":576507636},{"date":"2022-08-05","current":-11.107725,"twenty":-21.062795,"median":-8.674304,"eighty":-3.89073,"marketCap":608192372},{"date":"2022-08-12","current":-11.044212,"twenty":-21.057369,"median":-8.686118,"eighty":-3.902788,"marketCap":604714779},{"date":"2022-08-19","current":-6.087169,"twenty":-21.027635,"median":-8.674304,"eighty":-3.912344,"marketCap":400919180},{"date":"2022-08-26","current":-5.735068,"twenty":-20.992994,"median":-8.648165,"eighty":-3.917696,"marketCap":377728757},{"date":"2022-09-02","current":-5.597808,"twenty":-20.953825,"median":-8.640812,"eighty":-3.930533,"marketCap":368688422},{"date":"2022-09-09","current":-5.520226,"twenty":-20.872033,"median":-8.630797,"eighty":-3.94283,"marketCap":363578668},{"date":"2022-09-16","current":-7.849101,"twenty":-20.73156,"median":-8.578381,"eighty":-3.96417,"marketCap":516965327},{"date":"2022-09-23","current":-8.510226,"twenty":-20.611725,"median":-8.513329,"eighty":-3.972574,"marketCap":560509001},{"date":"2022-09-30","current":-10.493601,"twenty":-20.565232,"median":-8.578381,"eighty":-3.993719,"marketCap":691140025},{"date":"2022-10-07","current":-10.198204,"twenty":-20.477427,"median":-8.630797,"eighty":-4.008882,"marketCap":671684341},{"date":"2022-10-14","current":-10.950762,"twenty":-20.387531,"median":-8.642079,"eighty":-4.009677,"marketCap":721250013},{"date":"2022-10-21","current":-11.562654,"twenty":-20.357199,"median":-8.654251,"eighty":-4.014693,"marketCap":761551073},{"date":"2022-10-28","current":-11.956516,"twenty":-20.32892,"median":-8.675551,"eighty":-4.030286,"marketCap":787491986},{"date":"2022-11-04","current":-12.005748,"twenty":-20.283001,"median":-8.686118,"eighty":-4.065307,"marketCap":790734600},{"date":"2022-11-11","current":-15.768029,"twenty":-20.180562,"median":-8.713449,"eighty":-4.079563,"marketCap":830439027},{"date":"2022-11-18","current":-16.115182,"twenty":-20.035419,"median":-8.773737,"eighty":-4.104617,"marketCap":848722157},{"date":"2022-11-25","current":-16.060368,"twenty":-20.023491,"median":-8.779267,"eighty":-4.104763,"marketCap":845835347},{"date":"2022-12-02","current":-16.425792,"twenty":-19.948284,"median":-8.800314,"eighty":-4.104763,"marketCap":865080747},{"date":"2022-12-09","current":-15.384334,"twenty":-19.937676,"median":-8.842235,"eighty":-4.115583,"marketCap":810231356},{"date":"2022-12-16","current":-15.39347,"twenty":-19.766046,"median":-8.880178,"eighty":-4.122926,"marketCap":810712491},{"date":"2022-12-23","current":-15.548775,"twenty":-19.620281,"median":-8.920409,"eighty":-4.130826,"marketCap":818891787},{"date":"2022-12-30","current":-16.599368,"twenty":-19.607217,"median":-8.936255,"eighty":-4.130945,"marketCap":874222313},{"date":"2023-01-06","current":-15.777165,"twenty":-19.59823,"median":-8.94733,"eighty":-4.146129,"marketCap":830920162},{"date":"2023-01-13","current":-17.101825,"twenty":-19.554345,"median":-9.043188,"eighty":-4.162328,"marketCap":900684738},{"date":"2023-01-20","current":-16.106046,"twenty":-19.478065,"median":-9.066475,"eighty":-4.171098,"marketCap":848241022},{"date":"2023-01-27","current":-15.420877,"twenty":-19.243528,"median":-9.155743,"eighty":-4.18158,"marketCap":812155896},{"date":"2023-02-03","current":-16.042097,"twenty":-18.988351,"median":-9.163635,"eighty":-4.19168,"marketCap":844873077},{"date":"2023-02-10","current":-16.416656,"twenty":-18.921278,"median":-9.21308,"eighty":-4.201222,"marketCap":864599612},{"date":"2023-02-17","current":-16.16086,"twenty":-18.818457,"median":-9.237619,"eighty":-4.208561,"marketCap":851127832},{"date":"2023-02-24","current":-15.567046,"twenty":-18.755454,"median":-9.279961,"eighty":-4.218427,"marketCap":819854057},{"date":"2023-03-03","current":-15.7863,"twenty":-18.713587,"median":-9.288903,"eighty":-4.239786,"marketCap":831401297},{"date":"2023-03-10","current":-12.695923,"twenty":-18.685623,"median":-9.337354,"eighty":-4.268913,"marketCap":744679346},{"date":"2023-03-17","current":-12.365944,"twenty":-18.625694,"median":-9.47488,"eighty":-4.277714,"marketCap":725324457},{"date":"2023-03-24","current":-11.450254,"twenty":-18.520909,"median":-9.51831,"eighty":-4.30099,"marketCap":671614641},{"date":"2023-03-31","current":-11.326512,"twenty":-18.333889,"median":-9.637448,"eighty":-4.31253,"marketCap":664356558},{"date":"2023-04-06","current":-11.343011,"twenty":-18.288121,"median":-9.673933,"eighty":-4.318821,"marketCap":665324302},{"date":"2023-04-14","current":-11.433755,"twenty":-18.224659,"median":-9.699267,"eighty":-4.318821,"marketCap":670646896},{"date":"2023-04-21","current":-12.012005,"twenty":-18.140723,"median":-9.745723,"eighty":-4.318821,"marketCap":704564136},{"date":"2023-04-28","current":-17.665967,"twenty":-18.140723,"median":-9.757173,"eighty":-4.324014,"marketCap":1036197283},{"date":"2023-05-05","current":-18.5444,"twenty":-18.345331,"median":-9.795122,"eighty":-4.333623,"marketCap":1087721785},{"date":"2023-05-12","current":-17.975574,"twenty":-18.548481,"median":-9.809491,"eighty":-4.342105,"marketCap":1227408161},{"date":"2023-05-19","current":-17.7789,"twenty":-18.385145,"median":-9.923908,"eighty":-4.345574,"marketCap":1213978850},{"date":"2023-05-26","current":-18.14807,"twenty":-18.548481,"median":-10.050322,"eighty":-4.359142,"marketCap":1239186528},{"date":"2023-06-02","current":-20.069433,"twenty":-18.624,"median":-10.097881,"eighty":-4.366759,"marketCap":1370381033},{"date":"2023-06-09","current":-21.42026,"twenty":-18.679679,"median":-10.133562,"eighty":-4.369631,"marketCap":1462618218},{"date":"2023-06-16","current":-20.925237,"twenty":-18.866911,"median":-10.16981,"eighty":-4.375728,"marketCap":1428817014},{"date":"2023-06-23","current":-21.134993,"twenty":-18.937913,"median":-10.21543,"eighty":-4.380543,"marketCap":1443139558},{"date":"2023-06-30","current":-19.937075,"twenty":-19.13128,"median":-10.25893,"eighty":-4.382308,"marketCap":1361343322},{"date":"2023-07-07","current":-19.327719,"twenty":-19.403716,"median":-10.300042,"eighty":-4.384874,"marketCap":1319735326},{"date":"2023-07-14","current":-19.516534,"twenty":-19.527631,"median":-10.366739,"eighty":-4.396081,"marketCap":1332627944},{"date":"2023-07-21","current":-18.778441,"twenty":-19.516534,"median":-10.433806,"eighty":-4.40569,"marketCap":1282229526},{"date":"2023-07-28","current":-18.083261,"twenty":-19.456456,"median":-10.472595,"eighty":-4.425522,"marketCap":1234761248},{"date":"2023-08-04","current":-18.684034,"twenty":-19.430709,"median":-10.508916,"eighty":-4.445846,"marketCap":1275783217},{"date":"2023-08-11","current":-19.793943,"twenty":-19.456456,"median":-10.529051,"eighty":-4.466169,"marketCap":1467760467},{"date":"2023-08-18","current":-19.297154,"twenty":-19.516534,"median":-10.56417,"eighty":-4.47125,"marketCap":1430922557},{"date":"2023-08-25","current":-21.788862,"twenty":-19.594416,"median":-10.725698,"eighty":-4.489816,"marketCap":1615687698},{"date":"2023-09-01","current":-22.790203,"twenty":-19.620281,"median":-10.783103,"eighty":-4.508424,"marketCap":1689939110},{"date":"2023-09-08","current":-21.773337,"twenty":-19.662379,"median":-10.81952,"eighty":-4.516812,"marketCap":1614536513},{"date":"2023-09-15","current":-22.891113,"twenty":-19.937195,"median":-10.874844,"eighty":-4.541754,"marketCap":1697421810},{"date":"2023-09-22","current":-21.88201,"twenty":-20.044607,"median":-10.927771,"eighty":-4.55153,"marketCap":1622594806},{"date":"2023-09-29","current":-20.640037,"twenty":-20.232827,"median":-10.973642,"eighty":-4.576935,"marketCap":1530500032},{"date":"2023-10-06","current":-20.546889,"twenty":-20.307025,"median":-10.998264,"eighty":-4.587214,"marketCap":1523592923},{"date":"2023-10-13","current":-21.191163,"twenty":-20.399581,"median":-11.044212,"eighty":-4.596272,"marketCap":1571367088},{"date":"2023-10-20","current":-20.127723,"twenty":-20.430908,"median":-11.063294,"eighty":-4.598275,"marketCap":1492510937},{"date":"2023-10-27","current":-22.829497,"twenty":-20.455558,"median":-11.08551,"eighty":-4.599291,"marketCap":1692852872},{"date":"2023-11-03","current":-25.350703,"twenty":-20.512907,"median":-11.133626,"eighty":-4.606404,"marketCap":1879805335},{"date":"2023-11-10","current":-18.349717,"twenty":-20.534125,"median":-11.159417,"eighty":-4.623679,"marketCap":1893819287},{"date":"2023-11-17","current":-18.699474,"twenty":-20.512907,"median":-11.219301,"eighty":-4.647268,"marketCap":1929916591},{"date":"2023-11-24","current":-19.986078,"twenty":-20.508077,"median":-11.235768,"eighty":-4.660326,"marketCap":2062703104},{"date":"2023-12-01","current":-19.642567,"twenty":-20.498333,"median":-11.326512,"eighty":-4.691605,"marketCap":2027250394},{"date":"2023-12-08","current":-19.523899,"twenty":-20.469266,"median":-11.343011,"eighty":-4.703566,"marketCap":2015003094},{"date":"2023-12-15","current":-21.372612,"twenty":-20.485729,"median":-11.403123,"eighty":-4.710056,"marketCap":2205803131},{"date":"2023-12-22","current":-21.178997,"twenty":-20.539127,"median":-11.433755,"eighty":-4.725299,"marketCap":2185820695},{"date":"2023-12-29","current":-22.378161,"twenty":-20.560916,"median":-11.460738,"eighty":-4.752445,"marketCap":2309582881},{"date":"2024-01-05","current":-21.616192,"twenty":-20.635863,"median":-11.478255,"eighty":-4.774704,"marketCap":2230942325},{"date":"2024-01-12","current":-24.694637,"twenty":-20.763319,"median":-11.573996,"eighty":-4.807425,"marketCap":2548659433},{"date":"2024-01-19","current":-28.378521,"twenty":-20.874895,"median":-11.672989,"eighty":-4.871722,"marketCap":2928862002},{"date":"2024-01-26","current":-30.347082,"twenty":-20.925237,"median":-11.754932,"eighty":-4.928537,"marketCap":3132031295},{"date":"2024-02-02","current":-31.796601,"twenty":-20.995241,"median":-11.84903,"eighty":-5.022175,"marketCap":3281631848},{"date":"2024-02-09","current":-31.989395,"twenty":-21.094154,"median":-11.907283,"eighty":-5.032659,"marketCap":3301529459},{"date":"2024-02-16","current":-33.160435,"twenty":-21.134993,"median":-12.008876,"eighty":-5.086047,"marketCap":3422389019},{"date":"2024-02-23","current":-29.405371,"twenty":-21.18143,"median":-12.106086,"eighty":-5.094177,"marketCap":3321660162},{"date":"2024-03-01","current":-29.504379,"twenty":-21.252364,"median":-12.196466,"eighty":-5.100274,"marketCap":3332844203},{"date":"2024-03-08","current":-29.854208,"twenty":-21.362618,"median":-12.275201,"eighty":-5.134457,"marketCap":3372361147},{"date":"2024-03-15","current":-29.570385,"twenty":-21.39159,"median":-12.312278,"eighty":-5.167912,"marketCap":3340300230},{"date":"2024-03-22","current":-30.118229,"twenty":-21.456111,"median":-12.35282,"eighty":-5.193104,"marketCap":3402185256},{"date":"2024-03-28","current":-28.586905,"twenty":-21.586005,"median":-12.411316,"eighty":-5.211962,"marketCap":3229205423},{"date":"2024-04-05","current":-27.326204,"twenty":-21.698819,"median":-12.663882,"eighty":-5.224529,"marketCap":3086795302},{"date":"2024-04-12","current":-28.685913,"twenty":-21.801282,"median":-12.695915,"eighty":-5.23565,"marketCap":3240389464},{"date":"2024-04-19","current":-24.831203,"twenty":-21.90599,"median":-12.746573,"eighty":-5.260951,"marketCap":2804957470},{"date":"2024-04-26","current":-25.561122,"twenty":-21.970513,"median":-12.778856,"eighty":-5.33492,"marketCap":2887409933},{"date":"2024-05-03","current":-27.460667,"twenty":-22.002271,"median":-12.852662,"eighty":-5.443511,"marketCap":3101984415},{"date":"2024-05-10","current":-23.864016,"twenty":-22.106629,"median":-13.01501,"eighty":-5.504053,"marketCap":3075904561},{"date":"2024-05-17","current":-24.386628,"twenty":-22.316456,"median":-13.122963,"eighty":-5.514677,"marketCap":3143265660},{"date":"2024-05-24","current":-22.578036,"twenty":-22.408348,"median":-13.19089,"eighty":-5.517064,"marketCap":2910150846},{"date":"2024-05-31","current":-21.016071,"twenty":-22.408348,"median":-13.405255,"eighty":-5.517064,"marketCap":2708824416},{"date":"2024-06-07","current":-23.270938,"twenty":-22.480222,"median":-13.492753,"eighty":-5.517064,"marketCap":2999461067},{"date":"2024-06-14","current":-22.859895,"twenty":-22.573944,"median":-13.658594,"eighty":-5.526194,"marketCap":2946480428},{"date":"2024-06-21","current":-21.297929,"twenty":-22.578036,"median":-13.849482,"eighty":-5.550065,"marketCap":2745153997},{"date":"2024-06-28","current":-20.18224,"twenty":-22.604654,"median":-14.065248,"eighty":-5.737455,"marketCap":2601349404},{"date":"2024-07-05","current":-19.548058,"twenty":-22.604654,"median":-14.207014,"eighty":-5.875249,"marketCap":2519607846},{"date":"2024-07-12","current":-25.833502,"twenty":-22.663386,"median":-14.56294,"eighty":-6.158782,"marketCap":3329757590},{"date":"2024-07-15","current":-26.081274,"twenty":-22.683944,"median":-14.611833,"eighty":-6.204137,"marketCap":3361693680},{"date":"2024-08-02","current":-27.685273,"twenty":-22.729538,"median":-15.101131,"eighty":-7.080248,"marketCap":3568437841},{"date":"2024-08-09","current":-20.650678,"twenty":-22.791755,"median":-15.174216,"eighty":-7.173892,"marketCap":3174814544},{"date":"2024-08-16","current":-20.941919,"twenty":-22.791755,"median":-15.356928,"eighty":-7.243187,"marketCap":3219589736},{"date":"2024-08-23","current":-21.062812,"twenty":-22.791755,"median":-15.420877,"eighty":-7.280035,"marketCap":3238175665},{"date":"2024-08-30","current":-21.524403,"twenty":-22.791755,"median":-15.493961,"eighty":-7.318659,"marketCap":3309140119},{"date":"2024-09-06","current":-20.53528,"twenty":-22.791755,"median":-15.548775,"eighty":-7.330832,"marketCap":3157073430},{"date":"2024-09-13","current":-19.842894,"twenty":-22.791755,"median":-15.658402,"eighty":-7.386643,"marketCap":3050626748},{"date":"2024-09-20","current":-19.386799,"twenty":-22.791755,"median":-15.731487,"eighty":-7.41883,"marketCap":2980507108},{"date":"2024-09-27","current":-16.76013,"twenty":-22.791755,"median":-15.7863,"eighty":-7.470507,"marketCap":2576685567},{"date":"2024-10-04","current":-16.073239,"twenty":-22.791755,"median":-15.877656,"eighty":-7.496684,"marketCap":2471083699},{"date":"2024-10-11","current":-16.595276,"twenty":-22.791755,"median":-15.923334,"eighty":-7.600254,"marketCap":2551341118},{"date":"2024-10-18","current":-16.864537,"twenty":-22.791755,"median":-15.959877,"eighty":-7.641123,"marketCap":2592737050},{"date":"2024-10-25","current":-16.045763,"twenty":-22.791755,"median":-16.042097,"eighty":-7.711567,"marketCap":2466859624},{"date":"2024-10-31","current":-16.188637,"twenty":-22.791755,"median":-16.087775,"eighty":-7.784511,"marketCap":2488824813},{"date":"2024-11-08","current":-14.552491,"twenty":-22.793308,"median":-16.087775,"eighty":-7.860776,"marketCap":2592089652},{"date":"2024-11-15","current":-14.300163,"twenty":-22.793308,"median":-16.087775,"eighty":-7.961667,"marketCap":2547145116},{"date":"2024-11-22","current":-12.907511,"twenty":-22.793308,"median":-16.087775,"eighty":-8.046396,"marketCap":2299085853},{"date":"2024-11-29","current":-13.276297,"twenty":-22.793308,"median":-16.087775,"eighty":-8.103024,"marketCap":2364774020},{"date":"2024-12-06","current":-12.795905,"twenty":-22.793308,"median":-16.087775,"eighty":-8.12743,"marketCap":2279206539},{"date":"2024-12-13","current":-12.50961,"twenty":-22.793308,"median":-16.087775,"eighty":-8.178203,"marketCap":2228211778},{"date":"2024-12-20","current":-12.029218,"twenty":-22.793308,"median":-16.087775,"eighty":-8.232893,"marketCap":2142644297},{"date":"2024-12-27","current":-12.54843,"twenty":-22.793308,"median":-16.087775,"eighty":-8.272654,"marketCap":2235126322},{"date":"2025-01-03","current":-12.208758,"twenty":-22.793308,"median":-16.087775,"eighty":-8.306032,"marketCap":2174624062},{"date":"2025-01-10","current":-12.058333,"twenty":-22.79486,"median":-16.087775,"eighty":-8.349042,"marketCap":2147830205},{"date":"2025-01-17","current":-11.024761,"twenty":-22.79486,"median":-16.087775,"eighty":-8.387198,"marketCap":1963730473},{"date":"2025-01-24","current":-11.301351,"twenty":-22.79486,"median":-16.087775,"eighty":-8.421336,"marketCap":2012996598},{"date":"2025-01-31","current":-11.587645,"twenty":-22.79486,"median":-16.087775,"eighty":-8.512709,"marketCap":2063991360},{"date":"2025-02-07","current":-11.626465,"twenty":-22.79486,"median":-16.087775,"eighty":-8.629402,"marketCap":2070905904},{"date":"2025-02-14","current":-6.537248,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1794324147},{"date":"2025-02-21","current":-6.930226,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1902187506},{"date":"2025-02-28","current":-6.455028,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1771756793},{"date":"2025-03-07","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-03-14","current":-6.046805,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1659708933},{"date":"2025-03-21","current":-5.880964,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1614189490},{"date":"2025-03-28","current":-5.558851,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1525776725},{"date":"2025-04-04","current":-4.965652,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1362957177},{"date":"2025-04-11","current":-5.029437,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1380464656},{"date":"2025-04-17","current":-5.160196,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1416354986},{"date":"2025-04-25","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-05-02","current":-6.528381,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1791890393},{"date":"2025-05-09","current":-5.185048,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1592240087},{"date":"2025-05-16","current":-4.936919,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1516043779},{"date":"2025-05-23","current":-5.327651,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1636031068},{"date":"2025-05-30","current":-5.718383,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1756018358},{"date":"2025-06-06","current":-6.01785,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1847979419},{"date":"2025-06-13","current":-6.354393,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1951326135},{"date":"2025-06-20","current":-6.234607,"twenty":-22.797965,"median":-16.087775,"eighty":-8.644345,"marketCap":1914541711},{"date":"2025-06-27","current":-6.357245,"twenty":-22.797965,"median":-16.087775,"eighty":-8.623821,"marketCap":1952201955},{"date":"2025-07-03","current":-6.303056,"twenty":-22.797965,"median":-16.087775,"eighty":-8.578381,"marketCap":1935561382},{"date":"2025-07-11","current":-6.5027,"twenty":-22.797965,"median":-16.087775,"eighty":-8.537547,"marketCap":1996868756},{"date":"2025-07-18","current":-6.300204,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1934685562},{"date":"2025-07-25","current":-7.081669,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2174660141},{"date":"2025-08-01","current":-6.94477,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2132620799},{"date":"2025-08-08","current":-5.919479,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1964095003},{"date":"2025-08-15","current":-6.437202,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2135876627},{"date":"2025-08-22","current":-6.50588,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2158663986},{"date":"2025-08-29","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-05","current":-6.822853,"twenty":-22.800061,"median":-16.094245,"eighty":-8.503193,"marketCap":2263836409},{"date":"2025-09-12","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-19","current":-6.92587,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2298017446},{"date":"2025-09-26","current":-6.785873,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2251566293},{"date":"2025-10-03","current":-7.184731,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2383908259},{"date":"2025-10-10","current":-7.076432,"twenty":-22.797965,"median":-16.087775,"eighty":-8.426063,"marketCap":2347974347},{"date":"2025-10-17","current":-7.314162,"twenty":-22.797965,"median":-16.087775,"eighty":-8.383627,"marketCap":2426853665},{"date":"2025-10-24","current":-7.506988,"twenty":-22.797965,"median":-16.087775,"eighty":-8.36786,"marketCap":2490833556},{"date":"2025-10-31","current":-8.346967,"twenty":-22.797965,"median":-16.087775,"eighty":-8.39891,"marketCap":2769540477},{"date":"2025-11-07","current":-16.280273,"twenty":-22.797965,"median":-16.115182,"eighty":-8.446927,"marketCap":2616842278},{"date":"2025-11-14","current":-17.354717,"twenty":-22.797965,"median":-16.176647,"eighty":-8.45396,"marketCap":2789545102},{"date":"2025-11-21","current":-18.085556,"twenty":-22.797965,"median":-16.210617,"eighty":-8.45396,"marketCap":2907018089},{"date":"2025-11-28","current":-19.427247,"twenty":-22.797965,"median":-16.280273,"eighty":-8.45396,"marketCap":3122677452},{"date":"2025-12-05","current":-19.639954,"twenty":-22.797965,"median":-16.315109,"eighty":-8.45396,"marketCap":3156867352},{"date":"2025-12-12","current":-18.303718,"twenty":-22.797965,"median":-16.365703,"eighty":-8.45396,"marketCap":2942084652},{"date":"2025-12-16","current":-18.200091,"twenty":-22.797965,"median":-16.380114,"eighty":-8.45396,"marketCap":2925428034}],"updateTime":1766011922295},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDYA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591988184","title":"IDEAYA Biosciences (IDYA): Valuation Check After Key Darovasertib Trial Milestone and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988184","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591988184?lang=en_us&edition=fundamental","pubTime":"2025-12-16 13:17","pubTimestamp":1765862221,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences (IDYA) just hit a key clinical milestone, completing enrollment in its pivotal OptimUM-02 trial of darovasertib for metastatic uveal melanoma, with additional IND clearances quietly broadening the pipeline behind that lead asset.\nSee our latest analysis for IDEAYA Biosciences.\nThe clinical momentum around darovasertib and fresh IND wins has helped IDEAYA build a strong backdrop, with a roughly 36 percent 3 month share price return and a standout 5 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/ideaya-biosciences-idya-valuation-check-after-key-darovasert","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/ideaya-biosciences-idya-valuation-check-after-key-darovasert","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDYA","BK4139","BK4097","LU2065732104.USD","PRGS"],"gpt_icon":0},{"id":"2590511214","title":"Sector Update: Health Care Stocks Mixed Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2590511214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590511214?lang=en_us&edition=fundamental","pubTime":"2025-12-11 22:18","pubTimestamp":1765462684,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF  up 0.3% and the iShares Biotechnology ETF  0.2% lower.Rezolute  shares were down more than 88% after the company said its phase 3 sunRIZE study evaluating ersodetug in patients with congenital hyperinsulinism did not meet its primary and key secondary endpoints.Sarepta Therapeutics  stock was down nearly 7% after the company said it has negotiated exchange agreements with a limited number of holders of its 1.25% convertible senior notes due 2027.IDEAYA Biosciences  shares were up nearly 3% after the company said it has completed its targeted full enrollment of 435 patients in the phase 2/3 trial evaluating darovasertib in combination with Pfizer's  crizotinib for the treatment of metastatic uveal melanoma, a form of ocular cancer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4533","IE00BJT1NW94.SGD","IDYA","BK4599","RZLT","LU0321505439.SGD","IE00BLSP4239.USD","BK4585","LU0306807586.USD","SG9999013999.USD","LABU","IE00BLSP4452.SGD","LU0306806265.USD","LU0225771236.USD","BK4007","LU1023059063.AUD","LU1057294990.SGD","BK4568","LU1894683264.USD","LU0868494617.USD","BK4592","BK4139","LU0985481810.HKD","BK4550","IE00BBT3K403.USD","LU0234572021.USD","SGXZ57979304.SGD","SG9999011175.SGD","LU1066053197.SGD","LU0321505868.SGD","IE0002270589.USD","SG9999001176.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","SG9999002232.USD","SG9999003800.SGD","SRPT","SG9999002224.SGD","BK4588","LU0122379950.USD","LU1883839398.USD","IE00BFTCPJ56.SGD","BK4581","LU0289739699.SGD","IE0009355771.USD","BK4534","IE0002141913.USD","IE000M9KFDE8.USD","XBI","LU0225284248.USD","LU1894683348.USD","LU0456855351.SGD","BK7095","LU0170899867.USD","LU1066051498.USD","IE00B2B36J28.USD","IE00B19Z3B42.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2590597931","title":"IDEAYA Biosciences Completes Enrollment in Pivotal Phase 2/3 Trial of Darovasertib and Crizotinib for Metastatic Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590597931","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590597931?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:00","pubTimestamp":1765450857,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences Completes Enrollment in Pivotal Phase 2/3 Trial of Darovasertib and Crizotinib for Metastatic Uveal Melanoma. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via PR Newswire  on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL9sPG9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","BK4581","LU1883839398.USD","LU0225284248.USD","LU1057294990.SGD","LU0321505439.SGD","LU0225771236.USD","LU0306806265.USD","LU0456855351.SGD","LU0170899867.USD","SG9999002224.SGD","BK4007","SGXZ57979304.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4550","LU1066051498.USD","LU1894683264.USD","BK4533","LU0289739699.SGD","IE000M9KFDE8.USD","LU1894683348.USD","IDYA","BK4592","IE00BBT3K403.USD","SG9999011175.SGD","BK4139","LU0058720904.USD","LU0234572021.USD","SG9999013999.USD","SG9999002232.USD","BK4599","IE0002270589.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","IE00B19Z3581.USD","BK4588","SG9999001176.SGD","SG9999003800.SGD","BK4585","SG9999001176.USD","LU0122379950.USD","LU0985481810.HKD","LU1066053197.SGD","BK4534","BK4568","LU0868494617.USD"],"gpt_icon":0},{"id":"2590597642","title":"IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (Optimum-02) of Darovasertib in Combination With Crizotinib in First-Line Hla*a2-Negative Metastatic Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590597642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590597642?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:00","pubTimestamp":1765450800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA20RTFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2590597104","title":"IDEAYA Biosciences Inc - Topline Data Expected in 1Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590597104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590597104?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:00","pubTimestamp":1765450800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA20RTFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2590581969","title":"IDEAYA Biosciences Submits US FDA Investigational New Drug Application for Potential Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2590581969","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590581969?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:54","pubTimestamp":1765367699,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences  said Wednesday it has submitted an investigational new drug application to the US Food and Drug Administration for IDE574, a potential therapy for lung and breast cancer.The company said it is planning to begin a phase 1 dose escalation trial of the drug as a monotherapy in Q1 2026.The company said that preclinical studies to be published in H1 2026 show the potential therapy can target key enzymes in certain tumors to result in \"robust anti-tumor activity\" in lung and breast cancer models.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2590586420","title":"BRIEF-Ideaya Biosciences Announces Ind Submission For Ide574","url":"https://stock-news.laohu8.com/highlight/detail?id=2590586420","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590586420?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:02","pubTimestamp":1765364546,"startTime":"0","endTime":"0","summary":"BRIEF-Ideaya Biosciences Announces Ind Submission For Ide574Dec 10 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIOSCIENCES ANNOUNCES IND SUBMISSION FOR IDE574, A POTENTIAL FIRST-IN-CLASS KAT6/7 D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2590586483","title":"IDEAYA Biosciences- Phase 1 Dose Escalation Trial of Monotherapy Ide574 Expected to Begin in 1Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590586483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590586483?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:00","pubTimestamp":1765364458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2590558615","title":"IDEAYA Biosciences Announces Ind Submission for Ide574, a Potential First-in-Class Kat6/7 Dual Inhibitor for Breast and Lung Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2590558615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590558615?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:00","pubTimestamp":1765364458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2590258610","title":"IDEAYA Biosciences Inc - Preclinical Data for Ide574 to Be Presented in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590258610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590258610?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:00","pubTimestamp":1765364458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2590315296","title":"Is GSK’s Exit and IDE034’s FDA Green Light Reframing the Investment Case For IDEAYA Biosciences (IDYA)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590315296","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590315296?lang=en_us&edition=fundamental","pubTime":"2025-12-09 11:15","pubTimestamp":1765250157,"startTime":"0","endTime":"0","summary":"In early December 2025, GSK notified IDEAYA Biosciences that it will terminate their 2020 collaboration, returning the Werner Helicase (IDE275) and Pol Theta (IDE705) programs, while IDEAYA also secured FDA clearance to begin a Phase 1 trial of its bispecific B7H3/PTK7 ADC IDE034 for multiple solid tumors in 2026.\nThis combination of a major partnership unwind and the advancement of a potentially first-in-class oncology asset highlights IDEAYA’s increasing control over its pipeline and its...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/is-gsks-exit-and-ide034s-fda-green-light-reframing-the-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/is-gsks-exit-and-ide034s-fda-green-light-reframing-the-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSK.UK","BK4007","BK4588","BK4139","GSK","IDYA","BK4532","LU1829250122.USD","BK4585"],"gpt_icon":0},{"id":"2589870663","title":"Taking Stock of IDEAYA Biosciences (IDYA) Valuation After FDA Clears IDE034 for Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870663","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589870663?lang=en_us&edition=fundamental","pubTime":"2025-12-07 22:14","pubTimestamp":1765116897,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences (IDYA) just picked up fresh momentum after the FDA cleared its IND for IDE034, a first in class bispecific ADC targeting B7H3 and PTK7 in difficult solid tumors.\nSee our latest analysis for IDEAYA Biosciences.\nThe IDE034 news lands on a stock that has already been rerating, with an approximate 53 percent 3 month share price return and a 3 year total shareholder return of about 113 percent, suggesting momentum is still building as investors reassess the pipeline after GSK...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/taking-stock-of-ideaya-biosciences-idya-valuation-after-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/taking-stock-of-ideaya-biosciences-idya-valuation-after-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2589810574","title":"IDEAYA Biosciences Inc - to Evaluate Strategic Options for Programs in 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2589810574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589810574?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:23","pubTimestamp":1764969837,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0T7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2589381056","title":"IDEAYA Biosciences:on December 4, Glaxosmithkline Intellectual Property Terminated Collaboration Agreement With IDEAYA Biosciences - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589381056?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:23","pubTimestamp":1764969837,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2589855619","title":"IDEAYA and Biocytogen Receive FDA Clearance for IND Application of IDE034","url":"https://stock-news.laohu8.com/highlight/detail?id=2589855619","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589855619?lang=en_us&edition=fundamental","pubTime":"2025-12-05 07:59","pubTimestamp":1764892796,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals  Co., Ltd. announced that its business partner, IDEAYA Biosciences, Inc., has received clearance from the U.S. Food and Drug Administration  for an investigational new drug  application for IDE034, a potential first-in-class bispecific B7H3/PTK7 antibody-drug conjugate . This approval enables the initiation of a Phase 1 clinical trial, expected to begin patient enrollment in the first quarter of 2026, targeting solid tumors co-expressing B7H3 and PTK7. The IND clearance marks a significant milestone for both companies in advancing innovative cancer therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biocytogen Pharmaceuticals Beijing Co. Ltd. published the original content used to generate this news bri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDLf2bbC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","BK1161","BK4139","IDYA"],"gpt_icon":0},{"id":"2588774604","title":"BUZZ-U.S. STOCKS ON THE MOVE-Ideaya Biosciences, Omnicom Group, Targa Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588774604?lang=en_us&edition=fundamental","pubTime":"2025-12-02 00:53","pubTimestamp":1764607982,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Ideaya Biosciences, Omnicom Group, Targa ResourcesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL6N3X70KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FCEL","FLYE","OMC","AHMA","NVDY","KGS","SNPS","USAC","INR","TRGP","AAL","FANG","UAL","NVDU","IDA","EXC","ODFL","ALT","MRNA","CPNG","PAVS","DARE","BLTE","NVDS","NVAX","IDYA","LUV","ZS","CDE","LEG","QTTB","NVDD","TSYW.SI","HL","CLNE","ACN"],"gpt_icon":1},{"id":"2588877372","title":"Sector Update: Health Care Stocks Decline Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2588877372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588877372?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:18","pubTimestamp":1764598734,"startTime":"0","endTime":"0","summary":"Health care stocks were declining pre-bell Monday, with the Health Care Select Sector SPDR Fund  0.3% lower and the iShares Biotechnology ETF  down 0.6%.Belite Bio  shares were up more than 11% after the company said a phase 3 trial of Tinlarebant to treat Stargardt disease type 1 met its primary efficacy endpoint.Kestra Medical Technologies  stock was down more than 3% after the company reported a wider preliminary fiscal Q2 operating loss.IDEAYA Biosciences  shares were up more than 5% after the company said it has received clearance from the US Food and Drug Administration for an investigational new drug application to begin a Phase 1 trial of IDE034.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","XBI","BK4585","BK4082","LABU","XLV","BK4139","BLTE","KMTS","BK4581","BK4007","IBB","IDYA"],"gpt_icon":0},{"id":"2588377827","title":"BUZZ-Ideaya rises as FDA clears trial for experimental cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2588377827","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588377827?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:45","pubTimestamp":1764596708,"startTime":"0","endTime":"0","summary":"BUZZ-Ideaya rises as FDA clears trial for experimental cancer drug** Shares of California-based drug developer Ideaya Biosciences IDYA.O rise 3.3% to $36.80 premarket     ** Co says it has received clearance from U.S. FDA to begin its first human trial on its new experimental cancer drug, IDE034, which is designed to target several common types of solid tumors** Drug targets B7H3 and PTK7 proteins, often found together in lung, colorectal and head & neck cancers - IDYA** Co says these proteins are present in up to 46% of colorectal cancers, 30% of lung cancers, and 27% of head and neck cancers** In animal studies, IDE034 showed strong tumor-fighting effects, both on its own and when combined with co's another drug, IDE161 - IDYA** Co to begin enrolling patients in Q1 2026; more data expected at H1 2026 medical meeting** Up to last close, stock up ~39% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL4N3X714B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2588737721","title":"BRIEF-Ideaya Biosciences Announces Clearance For IDE034","url":"https://stock-news.laohu8.com/highlight/detail?id=2588737721","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588737721?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:33","pubTimestamp":1764588789,"startTime":"0","endTime":"0","summary":"BRIEF-Ideaya Biosciences Announces Clearance For IDE034Dec 1 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIOSCIENCES ANNOUNCES IND CLEARANCE FOR IDE034, A POTENTIAL FIRST-IN-CLASS BISPECIFIC B7H3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X40RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2588297337","title":"IDEAYA Biosciences Receives FDA IND Clearance for Phase 1 Trial of IDE034 in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588297337","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588297337?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:00","pubTimestamp":1764586839,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via PR Newswire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL78b2CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":134,"code":"91000000","status":"200"}]}}